إعلان
إعلان

BFRI

BFRI logo

Biofrontera Inc. Common Stock

0.82
USD
برعاية
0.00
-0.60%
٠٩ يناير, ١٥:٣٤ UTC -5
مغلق
exchange

بعد الإغلاق

0.81

-0.01
-0.61%

تقارير أرباح BFRI

النسبة الإيجابية المفاجئة

BFRI تفوق 4 من 17 آخر التقديرات.

24%

التقرير التالي

بيانات التقرير القادم
١٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$15.85M
/
$0.15
التغير الضمني من Q3 25 (Revenue/ EPS)
+126.79%
/
-124.19%
التغير الضمني من Q4 24 (Revenue/ EPS)
+26.19%
/
-160.00%

Biofrontera Inc. Common Stock earnings per share and revenue

On ١٢ نوفمبر ٢٠٢٥, BFRI reported earnings of -0.62 USD per share (EPS) for Q3 25, missing the estimate of -0.59 USD, resulting in a -4.80% surprise. Revenue reached 6.99 مليون, compared to an expected 7.14 مليون, with a -2.13% difference. The market reacted with a -8.59% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of 0.15 USD, with revenue projected to reach 15.85 مليون USD, implying an نقصان of -124.19% EPS, and زيادة of 126.79% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Biofrontera Inc. Common Stock reported EPS of -$0.62, missing estimates by -4.8%, and revenue of $6.99M, -2.13% below expectations.
The stock price moved down -8.59%, changed from $0.97 before the earnings release to $0.89 the day after.
The next earning report is scheduled for ١٩ مارس ٢٠٢٦.
Based on 4 المحللين, Biofrontera Inc. Common Stock is expected to report EPS of $0.15 and revenue of $15.85M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان